ResearchChronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly
ResearchPooled performance of urinary human papillomavirus (HPV) testing for the presence of cervical HPV
ResearchComprehensive clinical analysis of gastric-type endocervical adenocarcinoma: a real-world multicenter study
ResearchUnlocking the potential of patient-reported outcomes: practical uses in routine oncology care
ResearchCognitive Behavioral Therapy for Reproductive Concerns and Psychological Status in Reproductive-aged Breast Cancer Survivors: A Pretest-Posttest Intervention Study
ResearchInteractions among tumor subtype, PPARγ expression, and adipose proliferation shape outcomes in breast cancer
ResearchLow dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
ResearchCharacterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant
ResearchPhase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
ResearchGarsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
ResearchPhase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer
ResearchThe Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial